🇺🇸 Carboplatin AUC2 in United States

7 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alanine Aminotransferase Increased — 1 report (14.29%)
  2. Anaemia — 1 report (14.29%)
  3. Hypokalaemia — 1 report (14.29%)
  4. Kidney Infection — 1 report (14.29%)
  5. Packed Red Blood Cell Transfusion — 1 report (14.29%)
  6. Sepsis — 1 report (14.29%)
  7. Urinary Tract Infection — 1 report (14.29%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Carboplatin AUC2 approved in United States?

Carboplatin AUC2 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Carboplatin AUC2 in United States?

Merck Sharp & Dohme LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.